|
End-of-day quote
Korea S.E.
23/10/2026
|
5-day change | 1st Jan Change | ||
| 9,64,000.00 KRW | -4.46% |
|
-2.53% | +23.43% |
| 14/10 | Pharmicell Secures KRW7.4 Billion Supply Deal With Doosan | MT |
| 08/10 | Doosan Business Research Institute announced that it expects to receive KRW 400 million in funding from Doosan Corporation | CI |
Company Valuation: Doosan Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 19,38,758 | 13,27,149 | 14,89,665 | 38,98,767 | 1,26,02,701 | 1,45,26,675 | - | - |
| Change | - | -31.55% | 12.25% | 161.72% | 223.25% | 15.27% | - | - |
| Enterprise Value (EV) 1 | 7,235 | 5,977 | 4,864 | 8,470 | 16,903 | 18,799 | 18,425 | 17,250 |
| Change | - | -17.4% | -18.62% | 74.13% | 99.57% | 11.22% | -1.99% | -6.37% |
| P/E | 9.92x | -2.12x | -4.3x | -20.1x | 186x | 23x | 21x | 16.3x |
| PBR | 0.74x | 0.63x | 0.98x | 2.66x | 8.53x | 7.17x | 5.9x | 4.38x |
| PEG | - | 0x | 0.1x | 0.5x | -1x | 0x | 2.2x | 0.6x |
| Capitalization / Revenue | 0.14x | 0.08x | 0.08x | 0.22x | 0.64x | 0.67x | 0.58x | 0.51x |
| EV / Revenue | 0.53x | 0.35x | 0.25x | 0.47x | 0.85x | 0.86x | 0.73x | 0.6x |
| EV / EBITDA | 4.6x | 3.41x | 2.27x | 4.78x | 9.03x | 7.15x | 5.69x | 4.35x |
| EV / EBIT | 7.55x | 5.31x | 3.39x | 8.45x | 15.9x | 10.5x | 7.42x | 5.26x |
| EV / FCF | 21.1x | -35.8x | 3.67x | -21x | 41x | 21.9x | 17.1x | 11.2x |
| FCF Yield | 4.74% | -2.79% | 27.2% | -4.75% | 2.44% | 4.56% | 5.84% | 8.95% |
| Dividend per Share 3 | 2,050 | 2,000 | 2,000 | 2,000 | 4,000 | 4,489 | 5,014 | 5,197 |
| Rate of return | 1.74% | 2.41% | 2.13% | 0.78% | 0.51% | 0.47% | 0.52% | 0.54% |
| EPS 3 | 11,890 | -39,123 | -21,823 | -12,715 | 4,194 | 41,996 | 46,012 | 59,036 |
| Distribution rate | 17.2% | -5.11% | -9.16% | -15.7% | 95.4% | 10.7% | 10.9% | 8.8% |
| Net sales 1 | 13,728 | 16,996 | 19,130 | 18,132 | 19,784 | 21,829 | 25,110 | 28,575 |
| EBITDA 1 | 1,571 | 1,751 | 2,141 | 1,771 | 1,871 | 2,629 | 3,239 | 3,969 |
| EBIT 1 | 958.8 | 1,126 | 1,435 | 1,003 | 1,063 | 1,794 | 2,482 | 3,279 |
| Net income 1 | 656.7 | -696.4 | -388.3 | -226.2 | 75.78 | 570.4 | 681.7 | 951.3 |
| Net Debt 1 | 5,297 | 4,649 | 3,374 | 4,571 | 4,300 | 4,272 | 3,898 | 2,724 |
| Reference price 3 | 1,18,000.00 | 83,100.00 | 93,900.00 | 2,55,000.00 | 7,81,000.00 | 9,64,000.00 | 9,64,000.00 | 9,64,000.00 |
| Nbr of stocks (in thousands) | 17,800 | 17,800 | 17,800 | 17,800 | 17,840 | 17,882 | - | - |
| Announcement Date | 11/02/22 | 07/03/23 | 31/01/24 | 24/01/25 | 10/02/26 | - | - | - |
1KRW in Million2KRW in Billions3KRW
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 24.03x | 0.89x | 7.41x | 0.44% | 1.15TCr | |
| 26.31x | 4.51x | 20.14x | 0.88% | 32TCr | |
| 35.53x | 5.52x | 30.07x | 1.02% | 17TCr | |
| 15x | 1.15x | 7.39x | 4.91% | 6.38TCr | |
| 18.41x | 1.72x | 13.96x | 2.96% | 5.8TCr | |
| 29.62x | 4.17x | 17.41x | 0.44% | 4.64TCr | |
| 15.17x | 1.55x | 8.87x | 2.86% | 3.85TCr | |
| 11.04x | 1.04x | 10.43x | 4.73% | 3.44TCr | |
| 30.08x | 4.38x | 17.46x | 1.66% | 2.87TCr | |
| 12.33x | 0.4x | 4.15x | 3.99% | 2.6TCr | |
| Average | 21.75x | 2.53x | 13.73x | 2.39% | 8.04TCr | |
| Weighted average by Cap. | 25.49x | 3.76x | 18.92x | 1.74% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- A000150 Stock
- Valuation Doosan Corporation
Select your edition
All financial news and data tailored to specific country editions
